EPISODE · Aug 21, 2020 · 1H 2M
OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma
from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma
MIB Agents OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma ... Guest Information: *Richard Gorlick, MD Division Head, Dept Chair and Professor Pediatrics Director of the Pediatric Sarcoma Research Lab The University of Texas, MD Anderson Cancer Center *J. Andrew Livingston, MD Assistant Professor, Department of Sarcoma Medical Oncology Department of Pediatrics Co-leader for the MDACC Adolescent and Young Adult Program University of Texas MD Anderson Cancer Center *Sajad Khazal, MB. ChB. Assistant Professor, Department of Pediatrics Patient Care Division of Pediatrics The University of Texas MD Anderson Cancer Center Panelists: *Charlotte Murdoff OsteoWarrior & MIB Fund Holder *Ryan Kennington OsteoWarrior & MIB Agents Junior Board Member *Amanda Levine OsteoWarrior & Patient Advocate Hosted By Ann Graham, MIB Agents President ... Register for next week when we will be speaking with: Kurt Weiss, MD Fellow for Innovative Cancer Research Associate Professor, University of Pittsburgh School of Medicine Department of Orthopaedic Surgery/Musculoskeletal Oncology Vice Chair of Translational Research and Director of the Musculoskeletal Oncology Laboratory Baylor College of Medicine ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ...
Embed this episode
NOW PLAYING
OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.